Stock Analysis of Absci Corp (ABSI) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code ABSI
Close 3.97
Change -0.140 / 3.41 %
Volume 1493.83 K
Vol Change -758298.00 / 33.67 %
IndustryBiotechnology
SectorHealthcare
AIO Strength Index
Technical StrengthMild Bearish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Poor Profitability Stock
Stability Index Low Stability Stock


Fundamental View of Absci Corp


Highs/Lows of Absci Corp
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week4.03 1.49 % 1.97 % 4.553.8516-Jul-2415-Jul-24
Two Week3.17 25.24 % 1.12 % 4.553.2316-Jul-2408-Jul-24
One Month3.48 14.08 % 0.327 % 4.552.79516-Jul-2420-Jun-24
Three Month4.77 16.77 % 10.83 % 5.442.79503-May-2420-Jun-24
Six Months3.41 16.42 % 13.74 % 6.722.79509-Apr-2420-Jun-24
One year2.4 65.42 % 20.57 % 6.721.111109-Apr-2426-Oct-23
Two year3.58 10.89 % 39.84 % 6.721.111109-Apr-2426-Oct-23


Technical View of Absci Corp






Charts of Absci Corp


Returns of Absci Corp with Peers
Period / StockABSIESPRPACBALT
1 Week-1.49%-4.78%-1.19%-20.51%
1 Mth14.08%-12.13%0.912%6.26%
3 Mth-16.77%22.56%7.10%-9.12%
6mth16.42%18.32%-74.81%-32.11%
1 Year65.42%55.19%-87.86%96.25%
2 Year10.89%-63.51%-60.85%-44.18%
5 Years--94.45%-68.86%167.23%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Absci Corp with Peers
Ratio / StockABSIESPRPACBALT
PE-3.42-2066.39-1.46-910.78
P/B1.73-480.290.627495.32
ROA-42.70-33.62-16.39-49.56
ROE-50.450-43.05-54.38
Debt To Equity0.0396-0.5781.290.0026
Revenue6937.00 K
20.71 %
102902 K
36.34 %
169517 K
32.12 %
279000
510.29 %
Net Income-106492.00 K
1.51 %
-208391.00 K
10.81 %
-309101.00 K
1.64 %
-78466.00 K
7.37 %


Technicals of Absci Corp with Peers
Technical / StockABSIESPRPACBALT-
ADX23.9624.6822.0718.82
CMF-0.0128-0.2130.0250-0.154
MFI68.1264.0774.1254.00
RSI53.3547.6950.5941.20
MACD Abv SignalTrueTrueTrueFalse
Price Above 50 MAFalseFalseFalseFalse-
Price Above 200 MATrueTrueFalseFalse-


About : Absci Corp


Address : 18105 SE Mill Plain Boulevard, Vancouver, WA, United States, 98683
Tel : 360 949 1041
URL : https://www.absci.com
Code : ABSI, ISIN : US00091E1091, Exchange : NASDAQ, Country : USA
Fiscal Year End : December
IPO date : 22_Jul_2021
Employee Count : 155

Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.


Note : All Data Generated at the End of Trading Hours (EOD Data)